Trial
NCT04704050
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Tulane University School of Medicine
Collaborators
University of Washington; Marrek, INC; Sanofi; Preventice; Mckesson
Condition
Atrial Fibrillation
Intervention
dronedarone 400 mg Oral Tablet
Why stopped
Sponsor withdrew funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-30